Combined effects of panipenem and aminoglycosides on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in vitro

Chemotherapy

Volumn 51, Issue 6, 2005, Pages 387-391

  Katou, Ken ^a   Nakamura, Atsushi ^a   Kato, Takashi ^a   Tonegawa, Ken ^a   Kutsuna, Takeo ^a   Niwa, Toshiaki ^a   Morita, Hiroki ^a   Itoh, Makoto ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Antimicrobial combinations; Fractional inhibitory concentration; Methicillin resistant Staphylococcus aureus (MRSA); Panipenem; Pseudomonas aeruginosa

Indexed keywords

AGAR; AMIKACIN; AMINOGLYCOSIDE; HABEKACIN; NETILMICIN; PANIPENEM; VANCOMYCIN;

ARTICLE; BACTERIAL STRAIN; CULTURE MEDIUM; DILUTION; DRUG EFFECT; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; THIENAMYCINS;

EID: 27544496562     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088969     Document Type: Article

References (15)

1. Nakamura A, Hosoda M, Kato T, Yamada Y, Itoh M, Kanazawa K: Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitro. J Antimicrob Chemother 2000;46:901-904.
2. Nakazawa H, Kikuchi Y, Honda T, Isago T, Nozaki M: Enhancement of antimicrobial effects of various antibiotics against methicillin resistant Staphylococcus aureus (MRSA) by combination with fosfomycin. J Infect Chemother 2003;9:304-309.
3. Trias J, Nikaido H: Protein D2 channel of the Pseudomonas aeruginosa outer membrane has a binding site for basic amino acids and peptides. J Biol Chem 1990;265:15680-15684.
4. Goto S, Jo K, Kawakita T, Kosakai N, Mitsuhashi S, Nishno T: Determination method of minimum inhibitory concentrations. Jpn J Chemother 1981;29:76-79.
5. Hewlett PS: Measurement of potencies of drug mixture. Biometrics 1969;25:477-487.
6. Hiramatsu K, Aritaka N, Hanaki H: Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670-1673.
7. Jawetz E, Gunnison JB, Bruff JB, Coleman VR: Studies on antibiotic synergism and antagonism. Synergism among seven antibiotics against various bacteria in vitro. J Bacteriol 1952;1:29-39.
8. Gotoh N, Nishino T: Decreases of suspectibility to low molecular weight β-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion. J Antimicrob Chemother 1990;25:191-198.
9. Totsuka K, Shiseki M, Kikuchi K, Matsui Y: Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo. J Antimicrob Chemother 1999;44:455-460.
10. Sato S, Miura T, Kudo E, Kudo Y, Saitoh Y, Kimpara I: In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA. Jpn J Antibiot 1997;50:711-716.
11. Shibuya Y, Ohno T, Itoh K: Evaluation of arbekacin and antibacterial agents synergy for MRSA Isorated from blood cultures. Jpn J Chemother 2001;49:89-94.
12. Gerceker AA, Gurler B: In vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa. J Antimicrob Chemother 1995;36:707-711.
13. Ferrara A, Grassi G, Grassi FA, Piccioni PD, Gialdroni GG: Bactericidal activity of meropenem and interactions with other antibiotics. J Antimicrob Chemother 1989;24:239-250.
14. Muramatsu H, Horii T, Morita M, Hashimoto H, Kanno T, Maekawa M: Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosal isolates. Int J Med Microbiol 2003;293:191-197.
15. Sumita Y, Fukusawa M: Meropenem resistance in Pseudomonas aeruginosa. Chemotherapy 1996;42:47-56.